Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis.

BMC Pulm Med · 2021 · PMC8666028 · PMID 34895203

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

While a pooled effect on mortality was not demonstrated in the non-IPF studies in isolation, the beneficial effect on decline in FVC is shown for both IPF and non-IPF studies: it is very close in value and statistically highly significant for both groups.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.